Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.

MLA

Chari, Ajai, et al. “Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.” Clinical Lymphoma, Myeloma & Leukemia, vol. 24, no. 10, Oct. 2024, p. 665. EBSCOhost, https://doi.org/10.1016/j.clml.2024.05.003.

APA

Chari, A., Krishnan, A., Rasche, L., Ye, J. C., Garfall, A., Popat, R., Lipe, B., Qin, X., Campagna, M., Masterson, T., Tomlinson, C., Hilder, B., Tolbert, J., Renaud, T., Smit, M. D., Gray, K., Kane, C., Heuck, C., & van de Donk, N. W. C. J. (2024). Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab. Clinical Lymphoma, Myeloma & Leukemia, 24(10), 665. https://doi.org/10.1016/j.clml.2024.05.003

Chicago

Chari, Ajai, Amrita Krishnan, Leo Rasche, Jing Christine Ye, Alfred Garfall, Rakesh Popat, Brea Lipe, et al. 2024. “Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.” Clinical Lymphoma, Myeloma & Leukemia 24 (10): 665. doi:10.1016/j.clml.2024.05.003.